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SUMMARY
Background: Studies suggest obstructive sleep apnea
syndrome (OSAS) frequently manifests in patients with
gastroesophageal reflux disease (GERD) and that there
may be a causal relationship.
Aim: To determine the relationship between OSAS and
symptoms of GERD.
Methods: Consecutive patients referred to the Sleep Dis-
orders Center (SDC) 18 years and older with polysomno-
graphically defined OSAS were evaluated prospectively
for GERD using a validated symptoms questionnaire.
The GERD and OSAS relationship was assessed by
1) determining frequency of GERD in patients with and
without OSAS; 2) ascertaining the relationship between
OSAS severity categories and presence of GERD;
3) examining GERD score in relation to those factors
that might affect both GERD and OSAS, e.g. obesity.
Results: One thousand and twenty-three SDC patients
met entry citeria. Amongst participants, GERD was
common (29% of women and 17% of males) and OSAS
extremely common (58% of women and 80% of males).
GERD score did not correlate with OSAS variables. The
severity of OSAS did not influence the prevalence of
GERD.
Conclusion: In a large group of patients referred to a
sleep disorders center, there was no relationship
between OSAS and GERD symptoms. Also, there was
no relationship between the severity of OSAS and the
likelihood of GERD symptoms.
INTRODUCTION
Clinicians and interested researchers disagree whether
or not obstructive sleep apnoea syndrome (OSAS)
causes gastro-oesophageal reflux disease (GERD). In a
1989 letter, Samelson suggested that the negative
intrathoracic pressures generated during obstructive
apnoea events precipitated reflux.1 A year later, Diaz
et al. reported that five OSAS patients treated with
continuous positive airway pressure (CPAP) adminis-
tration manifested improvement in GERD.2 In 1992, a
study using both a 24-h pH monitor and polysomnog-
raphy in six OSAS patients with night-time GERD found
that both OSAS and GERD improved after the admin-
istration of nasal CPAP thus supporting the hypothesis
of an OSAS—GERD cause–effect relationship. However,
the authors could not establish a specific linkage
between GERD and apnoea events.3
More recent studies4–8 showed that OSAS patients
frequently manifest GERD, but did not establish a
cause–effect relationship. For example, Ing et al.6 deter-
mined that OSAS patients manifested more reflux and
greater time with an oesophageal pH below 4.0.
However, respiratory events preceded only 11% of the
reflux events. In addition, the putative OSAS–GERD
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cause–effect relationship is questioned by a recent study
of 228 patients. This study paired a validated GERD
questionnaire and nocturnal oximetry desaturations (as
a proxy for apnoeic and hypopnoeic events) to investi-
gate the relationship between OSAS and GERD.9 The
authors found no relationship between these surrogate
measures of GERD.
To date, studies have manifested flaws such as a small
number of subjects, lack of complete polysomnography,
as well as the inherent difficulty in assessing GERD.
GERD is defined as ‘…any symptomatic clinical condi-
tion or histopathological alteration resultant from
episodes of GER’.10 Unfortunately, no unassailable gold
standard exists for the diagnosis of GERD. One candi-
date, the expensive and relatively invasive 24-h pH
probe testing, has problems with sensitivity and reliab-
ility.11 For example, two studies revealed that 22 and
26% of patients with upper endoscopy documented
erosive oesophagitis manifested normal 24-h pH probe
test results.12, 13 Finally, in clinical practice the 24-h pH
probe is not indicated for the routine evaluation of
GERD but instead for the diagnosis of atypical sympto-
matology and for the assessment of subjects considering
antireflux surgery.14 Upper endoscopy also suffers flaws
as a tool for diagnosing GERD.14
However, multiple investigators do note the validity of
establishing GERD on the basis of symptoms.15–17 In
fact, clinicians typically diagnose and treat patients with
GERD on just such clinical grounds. Therefore, this
study used a succinct validated questionnaire specific-
ally designed for the diagnosis of GERD18 in a large
number of consecutive Sleep Disorders Center (SDC)
patients completing full polysomnography. The authors
hypothesized that using a validated GERD questionnaire
and polysomnography (the gold standard for the
diagnosis of OSAS) would provide data bolstering the
contention that OSAS causes GERD.
MATERIALS AND METHODS
Study population
The investigators selected the study population from
1342 consecutive patients referred to the Eastern
Virginia Medical School/Sentara Norfolk General Hos-
pital SDC. Included subjects were new SDC patients
‡18 years of age, who completed study questionnaires
as well as a diagnostic polysomnogram. Those patients
previously diagnosed with OSAS were excluded from the
study. The Institutional Review Board at Eastern
Virginia Medical School approved the study.
Study design and data collection
All patients underwent a standard history and physical
examination including review of medications and
computation of body mass index (BMI).
Before PSG (a study of sleep that incorporates
electroencephalography, electro-oculography, electro-
myography, respiratory and cardiac monitoring),
patients completed a brief 10-item GERD questionnaire
that was the sole tool used to diagnose GERD in this
study.18 The questionnaire addresses both frequency
and severity of GERD symptoms. This scale was devel-
oped utilizing content validation via literature review,
expert opinion, patient interviewing and extensive psy-
chometric evaluation. Additional validation included
convergent and predictive accuracy against doctor diag-
nosis. Research on this questionnaire identified a score of
15.5 or greater (S. Adlis, 2001, personal communica-
tion) as indicating GERD (from a range of 0–50).
Doctors ordered polysomnograms as indicated by the
patient’s intake interview and physical examination.
The polysomnogram determined the presence and
severity of OSAS. The apnoea hypopnoea index (AHI)
was defined as the number of apnoea and hypopnoea
events per hour. The complete cessation of airflow for
10 or more seconds defined apnoea. Hypopnoea events
were characterized by a 50% decrement in airflow and
2% desaturations. The investigators defined OSAS by an
AHI of 10 or greater. OSAS was subcategorized as mild,
10–19 events/h; moderate, 20–39 and severe, ‡40.
Diplomates of the American Board of Sleep Medicine
reviewed and interpreted all polysomnograms. During a
follow-up office visit after the polysomnogram, the
investigators reviewed the study results and discussed
treatment options with patients.
Statistical analysis
Statistical analyses were completed using the statistical
software program (SPSS, Chicago, IL, USA). Non-nor-
mally distributed data (AHI and the GERD score) were
transformed using 1+ natural log of AHI and the GERD
score. Untransformed mean values are used in the paper
while the statistical values are from the results using the
transformed data. The relationship between OSAS and
GERD was examined in several ways. We examined the
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Pearson correlation on the transformed data and exam-
ined the Spearman’s rho correlation between the GERD
score and OSAS frequency [including supine and rapid
eye movement (REM) sleep events] on the untransformed
data. The GERD score was examined in relation to factors
that might affect GERD and OSAS including age, BMI and
the use of antireflux medications. Using an anova, the
relationship between severity categories of OSAS and the
presence of GERD was analysed. Finally, the investigators
computed a linear regression analysis with variables
potentially related to GERD, i.e. age, BMI, caffeine use,
alcohol intake, non-steroidal anti-inflammatory drugs




A total of 1023 subjects completed the study. Gender,
ages, BMI, GERD scores and AHI for the analysed
groups are in Table 1. There was no difference in age
between men and women. Both men and women were
obese as defined by a BMI ‡ 30 kg/m2 with the women
having a greater BMI than men (t ¼ 4.91, d.f. ¼ 1022,
P < 0.001).
About 71% of the study group had OSAS. Of the men,
80% had OSAS (n ¼ 491) while of the women 58% had
OSAS (n ¼ 235; v2 ¼ 55.9, d.f. ¼ 1, P < 0.001). Male
subjects manifested a higher AHI (Table 1; t ¼ 8.64,
d.f. ¼ 1021, P < 0.001). In contrast to the apnoea
diagnosis, 29% of women and 17% of men had a GERD
score of ‡15.5. Women (mean ¼ 10.7 ± 11.7) scored
higher than men (mean ¼ 6.9 ± 8.8; t ¼ 5.94, d.f. ¼
1021, P < 0.001).
Correlations with GERD scores with Bonferroni corrections
Age did not correlate with GERD (r ¼ )0.022). There
was a small positive correlation with BMI (r ¼ 0.089,
P < 0.05). Over all subjects, the GERD score did not
significantly correlate with sleep apnoea variables
(overall AHI, supine AHI, REM sleep AHI, maximum
apnoea duration or arousals from sleep).
No significant correlation existed between GERD and
alcohol use, smoking and caffeine use. Positive correla-
tions occurred between GERD and antireflux medication
use [antacids, r ¼ 0.090; H2-blockers, r ¼ 0.179; pro-
ton-pump inhibitors (PPIs), r ¼ 0.246 and prokinetic
agents, r ¼ 0.117]. These were all significant at a
probability of <0.05 or better. Use of NSAIDs had a slight
but significant positive correlation with GERD (r ¼
0.090). Also, those with higher GERD scores took more
GERD medications. The score increased from 6.3 ± 8.7
for those taking no medication (n ¼ 726), to 13.1 ±
11.6 for those taking one GERD medication (n ¼ 272),
to 19.0 ± 11.8 for those taking two or more GERD
medications (n ¼ 25; F ¼ 65.4, d.f. ¼ 2, P < 0.001).
Group overlap
Figure 1 demonstrates that OSAS severity was not
related to the percentage of patients with GERD
(Pearson v2 ¼ 2.349, d.f. ¼ 3, P ¼ 0.503), i.e. there
was no increase in the percentage of patients with GERD
symptoms as the severity of apnoea increased. Although
the majority of our patients had OSAS (71%), only 22%
had GERD and only 15% of our patients had both GERD
and OSAS (Pearson v2 ¼ 2.376, d.f. ¼ 3, P ¼ 0.498).
Likewise, there was no relationship between the use of
GERD medications and the severity of OSAS (Table 2).
Regression
A binary logistic regression using the sleep-respiratory
variables in addition to age, BMI, caffeine use, alcohol
use, smoking and NSAID use indicated a relatively low








Mean 49.3 35.4 33.4 8.4
s.d. 12.5 8.6 31.9 10.2
Median 48.0 34.0 22.4 5.0
Men 617 (60%)
Mean 49.61 34.42 40.13 6.94
s.d. 12.4 7.5 32.9 8.8
Median 49.0 33.0 30.9 3.3
Women 406 (40%)
Mean 49.0 37.0 23.1 10.7
s.d. 12.5 9.9 27.2 11.7
Median 48.0 35.0 13.0 7.0
AHI, apnoea hypopnoea index; BMI, body mass index; GERD, gastro-
oesophageal reflux disease.
1 Difference in age between men and women was not significant.
2 Women had a greater BMI than men (P < 0.001).
3 Men had more frequent apnoea events than women (P < 0.001).
4 Women had higher GERD scores than men (P < 0.001).
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r2 of 0.038. The only significant predictor was BMI
(P ¼ 0.014). None of the sleep apnoea variables
predicted GERD.
To address the possibility that a GERD–OSAS relation-
ship might occur solely in those with the largest BMI,
we stratified the study participants into four BMI
groups: (i) normal (BMI: <25 kg/m2); (ii) overweight
(BMI: 25–29.9 kg/m2); (iii) obese (BMI: 30–39.9 kg/
m2) and (iv) severely obese (BMI: ‡40 kg/m2). Using an
anova, we determined that there was no three-way
interaction among these variables, i.e. there was no
relationship to the presence of GERD at any BMI group
for either men or women (F ¼ 0.319, d.f. ¼ 3, 1007,
P ¼ N.S.). In addition, there was no two-way interac-
tion between the presence of GERD and gender (F ¼
0.537, d.f. ¼ 1, 1007, P ¼ N.S.) or between the
presence of GERD and BMI group (F ¼ 0.996, d.f. ¼
3, 1007, P ¼ N.S.).
The difference between men and women in sleep
apnoea became most marked in the largest BMI group.
That is it was males who were apt to display the most
severe sleep apnoea. This was reflected in a gender by
BMI interaction (F ¼ 3.460, d.f. ¼ 3, 1007, P ¼
0.016).
DISCUSSION
A plausible and perhaps intuitive hypothesis is that
OSAS causes or exacerbates GERD. The large negative
intrathoracic pressures generated during apnoeic events
may draw gastric contents into the oesophagus, partic-
ularly in the context of arousals and movements that
accompany respiratory instability. Previous work has
indeed demonstrated nocturnal GER events during sleep
to follow short-lived arousals.19 An auxiliary hypothesis
is that even small amounts of refluxed material might
lead to a swallow with subsequent reduction in lower
oesophageal sphincter pressure and larger amounts of
reflux.3 Data do demonstrate that OSAS patients
frequently have GERD and more than one study has
demonstrated that CPAP treatment attenuates GERD.
A recent study in a large group of patients not only
demonstrated improvement in GERD with the applica-
tion of CPAP but also a weak relationship between AHI
and nocturnal reflux.20 As noted previously, the
working hypothesis of the present study was that
patients with OSAS would be more likely to have GERD
and that OSAS was likely a causative factor.
The results of this study however, run counter to the
argument that OSAS and symptoms of GERD are
related. In over 1000 SDC patients, there was no
correlation between the presence or absence of GERD
and OSAS. Additionally, there was no evidence for an
increased likelihood of GERD with increasing severity of
the AHI. This was despite increasing BMI with increas-
ing AHI, a trend that could have predisposed subjects to
an increased likelihood of GERD. As an example, one
study of over 1500 Olmstead County residents demon-
strated a BMI >30 kg/m2 to be associated with an
increased risk for GERD symptoms.17
A causal relationship between these two common
syndromes should have eventuated in an increased
frequency of GERD overall in OSAS subjects when
compared to those without OSAS. In addition, it is
plausible that with increasing severity of OSAS, more
GERD would have occurred in a dose–response rela-
tionship. Again, this was not found. Finally, it is of
interest that men were less likely than women in our
study to have GERD. This could have been due at least









No GERD Rx (%) 76.1 77.2 81.4 79.1
GERD Rx (%) 23.9 22.8 18.6 20.9
N 297 180 226 320
No apnoea, AHI < 10; mild, AHI ¼ 10–19.9; moderate, AHI ¼ 20–
39.9; severe AHI £ 40.
GERD, gastro-oesophageal reflux disease; OSAS, obstructive sleep
apnoea syndrome; Rx, medications.

















Figure 1. Percentage of patients with gastro-oesophageal reflux
disease (GERD) and obstructive sleep apnoea syndrome (OSAS).
There was no relationship between the percentage of patients with
GERD and the severity of OSAS (Pearson v2 ¼ 2.37, d.f. ¼ 3,
P ¼ 0.49).
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in part to our women subjects manifesting a higher
BMI. This reduced likelihood of GERD in men was in
spite of the fact that their AHI was higher than women.
Antireflux medications such as PPIs could reduce
GERD scores and hence potentially confound this study.
If the use of medications was in fact masking GERD
symptoms in GERD patients with OSAS, then a positive
correlation with OSAS should have been found. This
however was not the case. In fact, more patients
without sleep apnoea than with sleep apnoea were
taking GERD medications (Table 2).
Our results are consistent with other pertinent reports.
For example, one previously noted study,4 did not find a
relationship between severity of OSAS by AHI and GERD
as documented by pH probe. A more recent investiga-
tion with 228 patients also utilizing a validated
questionnaire (GERQ) did not establish a relationship
between OSAS and GERD.9 Finally, as in this study
recent work also utilized both polysomnography and a
validated GERD questionnaire (GERD Symptom Check-
list) to investigate OSAS and GERD. In 136 patients, the
authors stated that their data ‘…failed to show a causal
link between GERD and OSA’.21 Thus when one
includes this study, three different studies utilizing three
different validated questionnaires comprising some
1387 patients have not found a correlation between
OSAS and GERD. The strengths of the present study are
that it uses a validated GERD questionnaire, diagnoses
OSAS according to the ‘gold standard’, the nocturnal
polysomnogram, and that it is the largest study to date.
The authors believe that the GERD symptomatology in
OSAS patients may stem from promoting factors such as
obesity (via increased intra-abdominal pressure) and
perhaps the use of alcoholic beverages (although in our
study no such relationship was found).22 Men and
women in this study were obese and in fact the mean
BMI for those with an AHI of >40 almost reached severe
obesity at 39 kg/m2. Interestingly, a recent study using
a validated gastrointestinal (GI) questionnaire revealed
that the severely obese (mean BMI 47.8 kg/m2) noted
more severe GI symptoms including GERD.23
Although CPAP improves GER and suggests that OSAS
could be causative of GERD, it is possible that CPAP
operates through different mechanisms to improve
apnoea and GERD. CPAP both increases intrathoracic
pressure and may increase lower oesophageal sphincter
pressure.24 In the second instance, CPAP may work to
alleviate GERD through a mechanism that would have
little to do with OSAS. In addition, one study has
demonstrated that CPAP reduces regurgitant reflux in
achalasia, an unrelated illness to OSAS.25 Finally, Kerr
et al. have shown that GERD is reduced by CPAP in
patients without OSAS.24 The causal link between
OSAS and GERD because CPAP attenuates both patho-
logical events is therefore, tenuous.
A potential criticism of this study would be that all
patients were referred to the SDC, i.e. no subjects from
the general population were studied. However, an
unselected Olmstead County population manifested a
prevalence of weekly or greater GERD symptoms of
19.8%26 similar to this study. In addition, a study by
Valipour et al. of consecutive sleep disorders patients9
found a prevalence of weekly or greater GERD symp-
toms of 23.2%. In a study of 1000 primary care adult
patients from our catchment area, 24% admitted to
symptoms of GERD.27 Some other studies have found a
higher percentage of GERD symptoms. For example, two
studies noted frequencies of GERD in OSAS of 609 and
62%.13 However, these studies asked for symptoms
within the last 12 and 6 months while the validated
questionnaire in this study asked for GERD symptoms
within the last 4 weeks.
A recent report did use a validated questionnaire and
suggested that there was a significant correlation of
GERD symptoms and the AHI.28 This study however,
was relatively small (94 total patients; 26 patients with
OSAS and reflux symptoms present). The potential for
type 1 error is readily apparent, especially given that the
association of OSAS and GERD was not the primary
intent of the study.
It is also worth noting that from the standpoint of BMI,
this study’s population was not grossly dissimilar from
the general medical population. Recent work by the
authors that obtained 1000 primary care patients from
this same south-eastern Virginia referral community
revealed a mean BMI of 30.2 kg/m2.27 At least from the
standpoint of weight (a risk factor for both GERD and
OSAS) both study patients and our primary care
patients in this community would be identified as obese
under current National Institutes of Health guidelines.
Nevertheless a large-scale study investigating OSAS and
GERD that also includes normal controls would be of
interest.
Potentially this study would have been strengthened
by the use of a ‘more objective’ measure such as the
24-h pH probe or upper endoscopy. However, in a study
of this size large-scale use of such a measure would not
be feasible and again gastroenterologists do not agree
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that there is a ‘gold standard’ in the diagnosis of
GERD.12 The authors recognize that this study did not
replicate the previously alluded findings of Green et al.20
that demonstrated a weak relationship between AHI
and reflux. However, that study did not utilize a
validated questionnaire to assess GERD although it used
‘widely accepted’ terminology. Finally, a recent small
study using the 24-h pH probe and polysomnography
revealed a correlation between severity of OSAS and the
percentage time oesophageal pH measured <4. How-
ever, only 7% of reflux episodes occurred during sleep
and the timing of respiratory and reflux events did not
correlate.29 Despite the findings of this study it remains
possible that a subgroup of OSAS patients do suffer
increased GERD as a consequence of their sleep
disordered breathing. Symptoms of GERD and histolog-
ical findings do not always correlate. It is recognized
that there is a lack of correlation of the severity of
symptoms of GERD and the severity of acid exposure or
related erosive oesophagitis. Given that this study uses a
validated symptom assessment for GERD rather than pH
measurement, we are unable to comment as to potential
differences for acid contact time in OSAS patients.30, 31
Further work using both validated GERD questionnaire
and 24 h pH probe testing would be enlightening.
In conclusion, this study indicates that OSAS is not
associated with GERD as defined by symptoms. Shared
risks such as obesity probably explain the fact that
patients with OSAS frequently note symptoms of GERD.
Nevertheless, adult patients with both OSAS and GERD
may have both syndromes respond to the administration
of nasal CPAP. The authors recognize that CPAP is not a
validated treatment for GERD. However, a well done
population-based study has reported that 2% of women
and 4% of men aged 30–60 years have OSAS.32 In
addition, researchers utilizing a validated questionnaire
have determined that approximately 58% of Olmstead
County, MN, USA adult subjects admitted to reflux at
some time in the past year and over 19% at a weekly or
greater frequency.25 Therefore, given the complications
of GERD and the costs entailed in the use of long-term
PPIs, this ancillary benefit of CPAP may not be trivial.
ACKNOWLEDGEMENTS
The authors thank Dr Michael Shaw and AstraZeneca
for graciously allowing the use of the validated GERD
questionnaire. We also appreciate the staff of the EVMS/
SNGH SDC and participating patients.
Supported by the Division of Sleep Medicine/Department
of Internal Medicine, Eastern Virginia Medical School,
Sleep Academic Award HL03652-01A1, Excellence in
Primary Care Research Training (ExPRT) selected Fac-
ulty Trainee 2003–2005 (Faculty development grant:
HRSA no. D14-HP-00169-01) and Eastern Virginia
Medical School Student Summer Research Scholarship.
REFERENCES
1 Samelson CF. Gastro-oesophageal reflux and obstructive sleep
apnea. Sleep 1989; 12: 475–6.
2 Diaz S, Esteban E, Piro JM, Prados G, Villasante C. Utility of
CPAP in Gastroesophageal Reflux. Chest 1990; 97: 1275.
3 Kerr P, Shoenut JP, Millar T, et al. Nasal CPAP reduces gastro-
oesophageal reflux in obstructive sleep apnea syndrome. Chest
1992; 101: 1539–44.
4 Graf KI, Karaus M, Heinemann S, et al. Gastro-oesophageal
reflux in patients with sleep apnea syndrome. Z Gastroenterol
1995; 33: 689–93.
5 Penzel T, Becker HF, Brandenburg U, et al. Arousal in patients
with gastro-oesophageal reflux and sleep apnea. Eur Respir J
1999; 14: 1266–70.
6 Ing AJ, Ngu MC, Breslin ABX. Obstructive sleep apnea and
gastro-oesophageal reflux. Am J Med 2000; 108: 120S–5S.
7 Teramoto S, Ohga E, Matsui H, et al. Obstructive sleep apnea
syndrome may be a significant cause of gastro-oesophageal
reflux disease in older people. J Am Geriatr Soc 1999; 47:
1273–4.
8 Ozturk O, Ozturk L, Ozdogan A, et al. Variables affecting the
occurrence of gastro-oesophageal reflux in obstructive sleep
apnea patients. Eur Arch Otorhinolaryngol 2004; 261: 229–
32.
9 Valipour A, Makker HK, Hardy R, et al. Symptomatic gastro-
oesophageal reflux in subjects with a breathing sleep disorder.
Chest 2002; 121: 1748–53.
10 Kahrilas PJ. Gastro-oesophageal reflux disease and its
complications. In: Feldman M, Friedman LS, Sleisenger MH,
Scharschmidt MH, eds. Sleisenger and Fordtran’s Gastrointes-
tinal and Liver Diseases. Philadelphia, USA: W.B. Saunders,
1998: 498–517.
11 Locke GR, Talley NJ. 24-hour monitoring for gastro-
oesophageal reflux disease [letter]. Lancet 1993; 342: 1246–7.
12 Fass R, Ofman JJ, Gralnek IM, et al. Clinical and economic
assessment of the omeprazole test in patients with symptoms
suggestive of gastro-oesophageal reflux disease. Arch Intern
Med 1999; 159: 2161–8.
13 Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al. Omeprazole
as a diagnostic tool in gastro-oesophageal reflux disease. Am J
Gastroenterol 1997; 92: 1997–2000.
14 Soll AH, Fass R. Gastro-oesophageal reflux disease:
presentation and assessment of a common, challenging
disorder. Clin Cornerstone 2003; 5: 2–14.
15 Coyne KS, Wiklund I, Schmier J, et al. Development and
validation of a disease-specific treatment satisfaction
1132 H.-N. KIM et al.
 2005 Blackwell Publishing Ltd, Aliment Pharmacol Ther 21, 1127–1133
questionnaire for gastro-oesophageal reflux disease. Aliment
Pharmacol Ther 2003; 18: 907–15.
16 Pare P, Meyer F, Armstrong D, et al. Validation of the GSFQ, a
self-administered symptom frequency questionnaire for
patients with gastro-oesophageal reflux disease. Can J
Gastroenterol 2003; 17: 307–12.
17 Locke GR III, Talley NJ, Fett SL, et al. Risk factors associated
with symptoms of gastro-oesophageal reflux. Am J Med 1999;
106: 642–9.
18 Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a
diagnostic questionnaire for gastro-oesophageal reflux disease.
Am J Gastroenterol 2001; 96: 52–7.
19 Freidin N, Fisher MJ, Taylor W, et al. Sleep and nocturnal acid
reflux in normal subjects and patients with reflux
oesophagitis. Gut 1991; 32: 1275–9.
20 Green BT, Broughton WA, O’Connor JB. Marked improvement
in nocturnal gastro-oesophageal reflux in a large cohort of
patients with obstructive sleep apnea treated with continuous
positive airway pressure. Arch Intern Med 2003; 163: 41–5.
21 Morse CA, Quan SF, Mays MZ, et al. Is there a relationship
between obstructive sleep apnea and gastro-oesophageal
reflux disease? Clin Gastroenterol Hepatol 2004; 2: 761–8.
22 Watanabe Y, Fujiwara Y, Shiba M, et al. Cigarette smoking
and alcohol consumption associated with gastro-oesophageal
reflux disease in Japanese men. Scand J Gastroenterol 2003;
38: 807–11.
23 Foster A, Richards WO, McDowell J, et al. Gastrointestinal
symptoms are more intense in morbidly obese patients. Surg
Endosc 2003; 17: 1766–8.
24 Kerr P, Shoenut JP, Steens RD, et al. Nasal continuous positive
airway pressure. A new treatment for nocturnal gastro-
oesophageal reflux? J Clin Gastroenterol 1993; 17: 276–80.
25 Shoenut JP, Kerr P, Micflikier AB, et al. The effect of nasal
CPAP on nocturnal reflux in patients with a peristaltic
esophagus. Chest 1994; 106: 738–41.
26 Locke GR III, Talley NJ, Fett SL, et al. Prevalence and clinical
spectrum of gastro-oesophageal reflux: a population-based
study in Olmstead County, Minnesota. Gastroenterology
1997; 112: 1448–56.
27 Vorona RD, Winn MP, Babineau T, et al. Overweight and
obese patients in a primary care population report less sleep
than patients with a normal body mass index. Arch Intern
Med 2005; 165: 25–30.
28 Guda N, Partington S, Vakil N. Symptomatic gastro-
oesophageal reflux, arousals, and sleep quality in patients
undergoing polysomnography for possible obstructive sleep
apnoea. Aliment Pharmacol Ther 2004; 20: 1153–59.
29 Palombini LO, Robinson A, Black J, et al. Severity of sleep-
related breathing disorders correlates with severity of gastro-
oesophageal reflux disease in patients with heartburn and
sleep abnormalities [abstract]. Sleep 2004; 27: A232–3.
30 Johnson DA, Fennerty MB. Heartburn severity underestimates
erosive esophagitis severity in elderly patients with gastro-
oesophageal reflux disease. Gastroenterology 2004; 126:
660–4.
31 Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of
oesophagitis: clinical and functional correlates and further
validation of the Los Angeles classification. Gut 1999; 45:
172–80.
32 Young T, Palta M, Dempsey J, et al. The occurrence of sleep-
disordered breathing among middle-aged adults. NEJM 1993;
328: 1230–5.
OBSTRUCTIVE SLEEP APNOEA SYNDROME AND GASTRO-OESOPHAGEAL REFLUX DISEASE 1133
 2005 Blackwell Publishing Ltd, Aliment Pharmacol Ther 21, 1127–1133
